Contract drugmaker AMRI ($AMRI) is shifting some of its focus to early-stage R&D, partnering up with a neighboring biotech to expand its capabilities in drug ...
ALBANY, New York, Jan. 19, 2015 /PRNewswire/ -- AMRI (AMRI) today announced it received a 10-year federal contract award from the National Institutes of Health (NIH) for drug development and ...
ALBANY, N.Y., July 1, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced that it has completed the acquisition of Oso Biopharmaceuticals Manufacturing, a former portfolio company of Altaris ...
AMRI has acquired the outstanding equity interests of Aptuit's Glasgow, UK business and has entered into a definitive agreement to acquire Aptuit's SSCI/West Lafayette, Ind. business for total ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results